Literature DB >> 3264773

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

G Buchan1, K Barrett, M Turner, D Chantry, R N Maini, M Feldmann.   

Abstract

In rheumatoid arthritis there is a chronic immune and inflammatory reaction which can lead to the destruction of the diseased joint. Cytokine gene expression was studied in synovial cells using cDNA probes specific for human interleukin 1 (IL-1), -alpha and IL-1 beta, tumour necrosis factor (TNF), -alpha and TNF beta (lymphotoxin); protein molecules which induce cartilage degradation and bone resorption. In all cases studied, IL-1 mRNA was present in freshly isolated synovial cells from fluid or membrane. Compared to levels of IL-1 mRNA found in optimally activated normal blood mononuclear cells, the levels of IL-1 alpha mRNA were high in seven of the nine patients studied, whereas IL-1 beta mRNA, the dominant form in blood, was relatively lower. TNF alpha and TNF beta mRNA were also detected. Rheumatoid synovial cells, cultured without any stimulus, continued to express high levels of IL-1 alpha mRNA for up to 5 days, compared to the 24 h response of activated blood cells; IL-1 beta mRNA in culture was also prolonged. Cultures of rheumatoid joint cells produced IL-1 bioactivity, with roughly equal amounts of IL-1 alpha and beta, as assessed using neutralizing antibodies. TNF bioactivity was also detected which may be of importance as TNF induces the production of IL-1. The finding of these mediators produced in large amounts in active rheumatoid synovial cells suggests that mutually stimulatory cell interactions, mediated by these molecules, may be important in the chronic inflammation and tissue destruction in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264773      PMCID: PMC1541753     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  T cell clone producing an IL 1-like activity after stimulation by antigen-presenting B cells.

Authors:  B Tartakovsky; E J Kovacs; L Takacs; S K Durum
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

2.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples.

Authors:  B A White; F C Bancroft
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

4.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

5.  Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells.

Authors:  J M Dayer; C Zavadil-Grob; C Ucla; B Mach
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

6.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

7.  Recombinant human interleukin 1 alpha: purification and biological characterization.

Authors:  U Gubler; A O Chua; A S Stern; C P Hellmann; M P Vitek; T M DeChiara; W R Benjamin; K J Collier; M Dukovich; P C Familletti
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  Analysis of T-cell cultures and clones from a patient with classic rheumatoid arthritis--evidence for the existence of autoreactive T-cell clones in blood and synovial fluid.

Authors:  M Schlesier; C Ramb-Lindhauer; M Gärtner; H H Peter
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

9.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  83 in total

1.  Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Authors:  A K Ulfgren; L Gröndal; S Lindblad; M Khademi; O Johnell; L Klareskog; U Andersson
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 3.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells.

Authors:  Johnson D S Chang; Hou-Shan Lu; Ye-Fun Chang; David Wang
Journal:  Rheumatol Int       Date:  2004-11-27       Impact factor: 2.631

5.  The influence of anti-rheumatic drugs on hepatic mRNA levels of acute-phase proteins in rats with adjuvant arthritis.

Authors:  T Geiger; B Jagher; W Pignat; B Tscherry; I Wiesenberg
Journal:  Agents Actions       Date:  1993

6.  High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background.

Authors:  M Okamoto; M Takagi; M Kutsuna; Y Hara; M Nishihara; M C Zhang; T Matsuda; M Sakanaka; S Okamoto; M Nose; Y Ohashi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes.

Authors:  T Takizawa; S Nishinarita; N Kitamura; J Hayakawa; H Kang; Y Tomita; K Mitamura; K Yamagami; T Horie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 8.  Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)

Authors:  R N Maini; M J Elliott; F M Brennan; M Feldmann
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

Authors:  G D Anderson; S D Hauser; K L McGarity; M E Bremer; P C Isakson; S A Gregory
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.